ANAPTYSBIO, INC. Other Noncash Income (Expense)
ANAPTYSBIO, INC. (ANAB) reported Other Noncash Income (Expense) of -$60.18 million for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OtherNoncashIncomeExpense · last filed 2025-11-04
- ANAPTYSBIO, INC. other noncash income (expense) for the quarter ending 2025-09-30 was -$22.52M.
- ANAPTYSBIO, INC. other noncash income (expense) for the quarter ending 2025-06-30 was -$19.61M.
- ANAPTYSBIO, INC. other noncash income (expense) for the quarter ending 2025-03-31 was -$18.06M.
- ANAPTYSBIO, INC. other noncash income (expense) for the quarter ending 2024-09-30 was -$15.41M.
- ANAPTYSBIO, INC. other noncash income (expense) for fiscal 2023 was -$18.08M.
- ANAPTYSBIO, INC. other noncash income (expense) for fiscal 2022 was -$21.11M.
- ANAPTYSBIO, INC. other noncash income (expense) for fiscal 2021 was -$1.45M.
- ANAPTYSBIO, INC. other noncash income (expense) for fiscal 2020 was $0.00.
| Period end | Other Noncash Income (Expense) 3 month | Other Noncash Income (Expense) 6 month | Other Noncash Income (Expense) 9 month | Other Noncash Income (Expense) 12 month |
|---|---|---|---|---|
| 2025-09-30 | -$22.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$42.12M derived: sum of 2 quarters · filed 2025-11-04 | -$60.18M 10-Q · filed 2025-11-04 | |
| 2025-06-30 | -$19.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$37.67M 10-Q · filed 2025-08-06 | ||
| 2025-03-31 | -$18.06M 10-Q · filed 2025-05-05 | |||
| 2024-09-30 | -$15.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$26.37M derived: sum of 2 quarters · filed 2025-11-04 | -$32.68M 10-Q · filed 2025-11-04 | -$37.64M derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | -$10.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$17.27M 10-Q · filed 2025-08-06 | -$22.23M derived: sum of 3 quarters · filed 2025-08-06 | -$26.66M derived: sum of 4 quarters · filed 2025-08-06 |
| 2024-03-31 | -$6.32M 10-Q · filed 2025-05-05 | -$11.28M derived: sum of 2 quarters · filed 2025-05-05 | -$15.71M derived: sum of 3 quarters · filed 2025-05-05 | -$20.06M derived: sum of 4 quarters · filed 2025-05-05 |
| 2023-12-31 | -$4.96M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | -$9.39M derived: sum of 2 quarters · filed 2024-11-05 | -$13.75M derived: sum of 3 quarters · filed 2024-11-05 | -$18.08M 10-K · filed 2024-03-11 |
| 2023-09-30 | -$4.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | -$8.79M derived: sum of 2 quarters · filed 2024-11-05 | -$13.13M 10-Q · filed 2024-11-05 | -$17.38M derived: sum of 4 quarters · filed 2024-11-05 |
| 2023-06-30 | -$4.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | -$8.69M 10-Q · filed 2024-08-05 | -$12.95M derived: sum of 3 quarters · filed 2024-08-05 | -$19.08M derived: sum of 4 quarters · filed 2024-08-05 |
| 2023-03-31 | -$4.34M 10-Q · filed 2024-05-09 | -$8.59M derived: sum of 2 quarters · filed 2024-05-09 | -$14.72M derived: sum of 3 quarters · filed 2024-05-09 | -$20.59M derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | -$4.25M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | -$10.39M derived: sum of 2 quarters · filed 2024-03-11 | -$16.25M derived: sum of 3 quarters · filed 2024-03-11 | -$21.11M 10-K · filed 2024-03-11 |
| 2022-09-30 | -$6.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$12.00M derived: sum of 2 quarters · filed 2022-11-08 | -$16.86M 10-Q · filed 2022-11-08 | -$18.31M derived: sum of 4 quarters · filed 2024-03-11 |
| 2022-06-30 | -$5.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | -$10.72M 10-Q · filed 2022-08-08 | -$12.17M derived: sum of 3 quarters · filed 2024-03-11 | -$12.17M derived: sum of 4 quarters · filed 2024-03-11 |
| 2022-03-31 | -$4.85M 10-Q · filed 2022-05-04 | -$6.30M derived: sum of 2 quarters · filed 2024-03-11 | -$6.30M derived: sum of 3 quarters · filed 2024-03-11 | -$6.30M derived: sum of 4 quarters · filed 2024-03-11 |
| 2021-12-31 | -$1.45M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | -$1.45M derived: sum of 2 quarters · filed 2024-03-11 | -$1.45M derived: sum of 3 quarters · filed 2024-03-11 | -$1.45M 10-K · filed 2024-03-11 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $0.00 derived: sum of 2 quarters · filed 2022-11-08 | $0.00 10-Q · filed 2022-11-08 | $0.00 derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $0.00 10-Q · filed 2022-08-08 | $0.00 derived: sum of 3 quarters · filed 2023-03-01 | $0.00 derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-04 | $0.00 derived: sum of 2 quarters · filed 2023-03-01 | $0.00 derived: sum of 3 quarters · filed 2023-03-01 | $0.00 derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $0.00 derived: sum of 2 quarters · filed 2023-03-01 | $0.00 derived: sum of 3 quarters · filed 2023-03-01 | $0.00 10-K · filed 2023-03-01 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | $0.00 derived: sum of 2 quarters · filed 2020-11-04 | $0.00 10-Q · filed 2020-11-04 | -$173.00K derived: sum of 4 quarters · filed 2022-03-07 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $0.00 10-Q · filed 2020-08-10 | -$173.00K derived: sum of 3 quarters · filed 2022-03-07 | -$344.00K derived: sum of 4 quarters · filed 2022-03-07 |
| 2020-03-31 | $0.00 10-Q · filed 2020-05-06 | -$173.00K derived: sum of 2 quarters · filed 2022-03-07 | -$344.00K derived: sum of 3 quarters · filed 2022-03-07 | -$512.00K derived: sum of 4 quarters · filed 2022-03-07 |
| 2019-12-31 | -$173.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-07 | -$344.00K derived: sum of 2 quarters · filed 2022-03-07 | -$512.00K derived: sum of 3 quarters · filed 2022-03-07 | -$676.00K 10-K · filed 2022-03-07 |
| 2019-09-30 | -$171.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | -$339.00K derived: sum of 2 quarters · filed 2020-11-04 | -$503.00K 10-Q · filed 2020-11-04 | -$668.00K derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | -$168.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | -$332.00K 10-Q · filed 2020-08-10 | -$497.00K derived: sum of 3 quarters · filed 2021-02-25 | -$661.00K derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | -$164.00K 10-Q · filed 2020-05-06 | -$329.00K derived: sum of 2 quarters · filed 2021-02-25 | -$493.00K derived: sum of 3 quarters · filed 2021-02-25 | -$654.00K derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | -$165.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$329.00K derived: sum of 2 quarters · filed 2021-02-25 | -$490.00K derived: sum of 3 quarters · filed 2021-02-25 | -$646.00K 10-K · filed 2021-02-25 |
| 2018-09-30 | -$164.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | -$325.00K derived: sum of 2 quarters · filed 2019-11-08 | -$481.00K 10-Q · filed 2019-11-08 | -$640.00K derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | -$161.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$317.00K 10-Q · filed 2019-08-08 | -$476.00K derived: sum of 3 quarters · filed 2020-03-02 | -$633.00K derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-03-31 | -$156.00K 10-Q · filed 2019-05-07 | -$315.00K derived: sum of 2 quarters · filed 2020-03-02 | -$472.00K derived: sum of 3 quarters · filed 2020-03-02 | -$625.00K derived: sum of 4 quarters · filed 2020-03-02 |
| 2017-12-31 | -$159.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | -$316.00K derived: sum of 2 quarters · filed 2020-03-02 | -$469.00K derived: sum of 3 quarters · filed 2020-03-02 | -$619.00K 10-K · filed 2020-03-02 |
| 2017-09-30 | -$157.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$310.00K derived: sum of 2 quarters · filed 2018-11-08 | -$460.00K 10-Q · filed 2018-11-08 | -$485.00K derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-06-30 | -$153.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | -$303.00K 10-Q · filed 2018-08-07 | -$328.00K derived: sum of 3 quarters · filed 2019-02-28 | -$358.00K derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-03-31 | -$150.00K 10-Q · filed 2018-05-08 | -$175.00K derived: sum of 2 quarters · filed 2019-02-28 | -$205.00K derived: sum of 3 quarters · filed 2019-02-28 | -$233.00K derived: sum of 4 quarters · filed 2019-02-28 |
| 2016-12-31 | -$25.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | -$55.00K derived: sum of 2 quarters · filed 2019-02-28 | -$83.00K derived: sum of 3 quarters · filed 2019-02-28 | -$105.00K 10-K · filed 2019-02-28 |
| 2016-09-30 | -$30.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | -$58.00K derived: sum of 2 quarters · filed 2017-11-07 | -$80.00K 10-Q · filed 2017-11-07 | |
| 2016-06-30 | -$28.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | -$50.00K 10-Q · filed 2017-08-10 | ||
| 2016-03-31 | -$22.00K 10-Q · filed 2017-05-12 | |||
| 2015-12-31 | -$110.00K 10-K · filed 2018-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |